Sotirios Stergiopoulos is the Founder, President & CEO at A2A Pharmaceuticals. Previously, Sotirios was the Chief Medical Officer, SVP and Head of Global Medical Affairs at Ipsen. Sotirios holds a Masters of Biotechnology Enerprise and Entrepreneurship from Johns Hopkins University.
A2A Pharmaceuticals
A2A Pharmaceuticals is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents.